The study aims to determine the discriminatory thresholds, specificity, and sensitivity of the novel biomarkers FGF21, GDF15, and NOS in diagnosing mitochondrial dysfunction associated with pediatric anemia. This evidence concerns the gene FGF21 and anemia (phenotype).